Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207

Trial Profile

The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dasiglucagon (Primary) ; Glucagon; Insulin lispro
  • Indications Hypoglycaemia
  • Focus Adverse reactions
  • Sponsors Zealand Pharma

Most Recent Events

  • 07 Mar 2018 According to Zealand Pharma media release, results from this trial were presented at the Conference on Advanced Technologies & Treatments for Diabetes (2018).
  • 15 Feb 2018 According to Zealand Pharma media release, results (n=12) from this trial will be presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes (2018).
  • 22 Jun 2017 Results published in a Zealand Pharma media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top